July 21, 2022

Junshi Biosciences Receives Orphan Medicinal Product Designation from the European Committee for Toripalimab in Treatment of Nasopharyngeal Carcinoma

–6th Orphan Drug Designation granted to toripalimab in the US and EU SHANGHAI, China, July 21, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that toripalimab,

Read More

Darwin Aboriginal Art Fair set to showcase works from over 1,500 First Nations artists, represented by a record 76 community Art Centres from across Australia

DARWIN, Australia, July 21, 2022 (GLOBE NEWSWIRE) — Aboriginal and Torres Strait Islander creatives will be celebrated in Darwin, Australia, from 2-7 August in an unmissable showcase of art, design and culture at Darwin Aboriginal Art Fair (DAAF) Foundation’s series of iconic events. The Darwin Aboriginal Art Fair (DAAF) is

Read More